Beatrice Darimont

Title: Beatrice Darimont: Innovator in Nuclear Receptor Modulation

Introduction

Beatrice Darimont is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of nuclear receptor research. Her innovative work focuses on methods for modulating nuclear receptor coactivator binding, which has implications for various biological processes.

Latest Patents

Beatrice holds a patent titled "Methods for modulating nuclear receptor coactivator binding." This invention relates to methods and agonist/antagonist compounds for modulating nuclear receptor coactivator binding. The patent includes a method for identifying residues that comprise a coactivator binding site for a nuclear receptor of interest. Additionally, it provides a method for identifying agonists and/or antagonists that bind to a coactivator binding site of a nuclear receptor. The invention exemplifies the identification and manipulation of the coactivator binding site of the thyroid receptor (TR) and includes compounds that bind to these sites. The methods can also be applied to other nuclear receptors, including RAR, RXR, PPAR, VDR, ER, GR, PR, MR, and AR. Beatrice has 1 patent to her name.

Career Highlights

Beatrice is affiliated with the University of California, where she continues her research and development in the field of nuclear receptors. Her work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Beatrice has collaborated with notable colleagues, including John D Baxter and Weijun Feng. These collaborations have further enriched her research and contributed to advancements in the field.

Conclusion

Beatrice Darimont is a trailblazer in the realm of nuclear receptor modulation. Her innovative patent and ongoing research at the University of California highlight her commitment to advancing scientific knowledge and potential therapeutic applications.